Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: C-TAP
With technology transfer, 120 companies in low- and middle-income countries could...
Kaitlin Mara
-
February 15, 2022
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
Landmark decision by the World Health Assembly to start negotiations for...
Kaitlin Mara
-
December 1, 2021
Imagine if health and trade ministers would meet in one room...
Ellen 't Hoen
-
November 30, 2021
The EU proposed Covid waivers of certain TRIPS rules are mostly...
Medicines Law & Policy
-
October 14, 2021
Vaccine knowledge needs to be a global public good: Remarks to...
Ellen 't Hoen
-
July 22, 2021
Covid shows the world it needs new rules to deal with...
Ellen 't Hoen
-
May 21, 2021
Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination...
Kaitlin Mara
-
May 12, 2021
We need a Global Vaccines Taskforce, not just a British or...
Christopher Garrison
-
February 24, 2021
The elephant in the room at the WHO Executive Board
Ellen 't Hoen
-
January 22, 2021
1
2
Page 1 of 2
This work is licensed under Creative Commons.